Stough, C., et al. «Neuropsychological Changes After 30-Day Ginkgo Biloba Administration in Healthy Participants», International Journal of Neuropsychopharmacology 4, no. 2 (2001): 131–34.
Wesnes, K. A., et al. «The Memory Enhancing Effects of a Ginkgo Biloba/Panax Ginseng Combination in Healthy Middle-aged Volunteers», Psychopharmacology 152, no. 4 (2000): 353–61.
Yoshikawa, Т., Y. Naito, and M. Kondo, «Ginkgo Biloba Leaf Extract: Review of Biological Actions and Clinical Applications», Antioxidants and Redox Signaling 1, no. 4 (1999): 469–80.
Amaducc, L. and SMID Group, «Phosphatidylserine in the Treatment of Alzheimer’s Disease. Results of a Multicenter Study», Psychopharmacology Bulletin 24 (1988): 130–34.
Crook, T., et al. «Effects of Phosphatidylserine in Alzheimer’s Disease», Psychopharmacology Bulletin 28 (1992): 61–66.
Crook, Т. H., et al. «Effects of Phosphatidylserine in Age-Associated Memory Impairment», Neurology 41 (1991): 644–49.
Pepeu, G., I., Marconcini Pepeu, and L. Amaducc, «A Review of Phosphatidylserine Pharmacological and Clinical Effects. Is Phosphatidylserine a Drug for the Ageing Brain?» Pharmacological Research 33 (1996): 73–80.
Villardita, C., et al. «Multicentre Clinical Trial of Brain Phophatidylserine in Elderly Patients with Intellectual Deterioration», Clinical Trials Journal 24 (1987): 84–93.
Zanott, A., L. Valzelli, and G. Toffano, «Chronic Phosphatidylserine Treatment Improves Spatial Memory and Passive Avoidance in Aged Rats», Psychopharmacology 99 (1989): 316–21.
Juneja, L. R., et al. «L-Theanine-A Unique Amino Acid of Green Tea and Its Relaxation Effect in Humans», Trends in Food Science and Technology 10 (1999): 199–204.
Lu, K., et al. «The Acute Effects of L-Theanine in Comparison with Alprazolam on Anticipatory Anxiety in Humans», Human Psychopharmacology 19, no. 7 (October 2004): 457–65.
Sadzuka, Y., et al. «The Effects of Theanine, as a Novel Biochemical Modulator, on the Antitumor Activity of Adriamycin», Cancer Letters 105 (1996): 203–09.
Bereczki, D., and I. Fekete, «A Systematic Review of Vinpocetine Therapy in Acute Ischaemic Stroke», European Journal of Clinical Pharmacology 55 (1999): 349–52.
Gulyas, B., et al. «Brain Uptake and Plasma Metabolism of [11C] Vinpocetine: A Preliminary PET Study in a Cynomolgus Monkey», Journal of Neuroimaging 9 (1997): 217–22.
Sitges, М., and V. Nekrassov, «Vinpocetine Prevents 4-Aminopyridine-Induced Changes in the EEG, the Auditory Brainstem Responses and Hearing», Clinical Neurophysiology 115, no. 12 (December 2004): 2711–17.
Thai, L. J., et al. «The Safety and Lack of Efficacy of Vinpocetine in Alzheimer’s Disease», Journal of the American Geriatrics Society 37 (1989): 515–20.
Fletcher, R. H., and К. M. Fairfield, «Vitamins for Chronic Disease Prevention in Adults: Clinical Applications», Journal of the American Medical Association 287, no. 23 (June 19, 2002): 3127–29.
Aarsand, A. К., and S. M. Carlsen, «Folate Administration Reduces Circulating Homocysteine Levels in NIDDM Patients on Long-term Metformin Treatment», Journal of Internal Medicine 244 (1998): 169–74.
Anon., «How Folate Fights Disease», Nature Structural Biology 6 (1999): 293–94.
Baik, H. W., and R. M. Russell, «Vitamin B12 Deficiency in the Elderly», Annual Review of Nutrition 19 (1999): 357–77.
Berry, R. J., et al. «Prevention of Neural-Tube Defects with Folic Acid in China», New England Journal of Medicine 341 (1999): 1485–90.
Bottiglieri, T., «Folate, Vitamin B12, and Neuropsychiatric Disorders», Nutrition Reviews 54 (1996): 382–90.